PATENT CLAIM ANALYSIS

Application Number: 15951866
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "570000"]

Abstract:
Technologies are described for a formulation and production of a formulation. The methods may comprise depositing a non-steroidal anti-inflammatory drug (NSAID) compound into a chamber. The methods may comprise depositing a N-methyl-D-aspartate (NMDA) receptor antagonist into the chamber. The methods may comprise respectively depositing a muscle relaxant, a local anesthetic into the chamber, depositing an anticonvulsant into the chamber, depositing an antidepressant into the chamber, and depositing a calcium channel blocking agent into the chamber. The methods may comprise milling the NSAID compound, the NMDA receptor antagonist, the muscle relaxant, the local anesthetic, the anticonvulsant, the antidepressant, and the calcium channel blocking agent into a powder. The methods may comprise adding a solvent with the powder and mixing the solvent with the powder to form a solution. The methods may comprise adding a base cream to the solution and mixing the base cream and the solution to form the formulation.

Claim (Index 10):
The formulation of  claim 1 , further comprising:\n about 5 to about 10 weight percent of the nonsteroidal anti-inflammatory drug (NSAID); about 5 to about 10 weight percent of the N-methyl-D-aspartate (NMDA) receptor antagonist; about 2 to about 10 weight percent of the muscle relaxant; about 2 to about 5 weight percent of the local anesthetic; about 3 to about 10 weight percent of the anticonvulsant; about 3 to about 5 weight percent of the antidepressant; about 0.02 to about 0.05 weight percent of the calcium channel blocking agent; a solvent; and a base cream.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 3.22642
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15229434', '13448088', '13328369', '10576152', '14916141']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256755849781618
- 35 USC 102 Novelty (BERT): 0.522358664515796
- Combined Prediction Score: 0.7053438929319252
- Mean Citation Score: 248.62927
- Max Citation Score: 336.94916
- Similarity Product: 281.9239035465622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test